2[2]Avery GB,Fletcher MA,MacDonald MG.Neonatology pathophysiology & management of the newborn.5th ed.Philadelphia:Lippincott Williams & Wilkins,1999.509
3[5]Lyon A.Chronic lung disease of prematurity:the role of intra-uterine infection.Eur J Pediatr,2000,159:798
4[6]De Dooy JJ,Mahieu LM,Van Bever HP.The role of inflammation in the development of chronic lung disease in neonates.Eur J Pediatr,2001,160:457
5[8]Halliday HL,Ehrenkranz RA,Doyle LW.Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.Cochrane Database Syst Rev,2003(1):CD001145
6[9]Groneck P.Perinatal glucocorticosteroid therapy:time for reconsideration.Z Geburtshilfe Neonatol,2001,205(6):231
7[10]LeFlore JL,Salhab WA,Broyles RS,et al.Association of antenatal and postnatal dexamethasone exposure with outcomes in extremely low birth weight neonates.Pediatrics,2002,110(2 Pt 1):275
6Subramaniam P, Henderson-Smart DJ, Davis PG. Prophylactic nasal continuous positive airways pressure for preventing morbidity and mortality in very preterm infants[J]. Cochrane Database Syst Rev, 2005 ,(3) :CD001243.
7Herring E, Rauprich P, Stichtenoth G, et al. Resistance of different surfactant preparations to inactivation by meconium [J]. Pediatr Res, 2001,50(1) :44-49.
8Marco P,Daniele DL,Domenico P,et al.Noninvasive pressure support ventilation in immunocompromised children with ARDS:a feasibility study[J].Intensive Care Med, 2009,35 (4) : 1420.
